Vaxart Inc. (VXRT)
NASDAQ: VXRT
· Real-Time Price · USD
0.56
-0.00 (-0.07%)
At close: Jun 24, 2025, 3:59 PM
0.55
-1.53%
After-hours: Jun 24, 2025, 07:37 PM EDT
-0.07% (1D)
| Bid | 0.53 |
| Market Cap | 128.24M |
| Revenue (ttm) | 47.4M |
| Net Income (ttm) | -58.12M |
| EPS (ttm) | -0.26 |
| PE Ratio (ttm) | -2.16 |
| Forward PE | -1.48 |
| Analyst | Buy |
| Ask | 0.59 |
| Volume | 2,571,565 |
| Avg. Volume (20D) | 4,290,804 |
| Open | 0.56 |
| Previous Close | 0.56 |
| Day's Range | 0.55 - 0.60 |
| 52-Week Range | 0.28 - 1.07 |
| Beta | 1.15 |
About VXRT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VXRT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VXRT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+28.3%
Vaxart shares are trading higher after the company...
Unlock content with
Pro Subscription
5 months ago
+1.5%
Vaxart shares are trading higher after the company announced its Phase 2b COVID-19 trial received Independent Data Safety Monitoring Board (DSMB) approval and will expand its testing to 10,000 participants.
